# Masao Omata

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/masao-omata/

## Facts

| Field | Value |
| --- | --- |
| Citations | 75,640 |
| Field | Liver Disease Diagnosis and Treatment |
| h-index | 134 |
| i10-index | 835 |
| Last Known Institution | University of Yamanashi Hospital |
| OpenAlex ID | https://openalex.org/A5034244372 |
| ORCID iD | https://orcid.org/0000-0001-7977-1497 |
| Works | 1,680 |

## Researcher papers

- [Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update](https://scholariq.org/papers/asian-pacific-clinical-practice-guidelines-on-the-management-of-hepatitis-b-a/)
- [Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update](https://scholariq.org/papers/asia-pacific-clinical-practice-guidelines-on-the-management-of-hepatocellular/)
- [Correction: Corrigendum: MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma](https://scholariq.org/papers/correction-corrigendum-microrna122-is-a-key-regulator-of-fetoprotein-expression/)
- [Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma](https://scholariq.org/papers/asian-pacific-association-for-the-study-of-the-liver-consensus-recommendations/)
- [The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease](https://scholariq.org/papers/the-asian-pacific-association-for-the-study-of-the-liver-clinical-practice/)
- [New Inuyama classification; new criteria for histological assessment of chronic hepatitis](https://scholariq.org/papers/new-inuyama-classification-new-criteria-for-histological-assessment-of-chronic/)
- [Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)](https://scholariq.org/papers/pre-existing-liver-disease-is-associated-with-poor-outcome-in-patients-with-sars/)
- [Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update](https://scholariq.org/papers/asian-pacific-association-for-the-study-of-the-liver-apasl-consensus-guidelines/)

## Researcher topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

## Researcher university

- [University of Yamanashi Hospital](https://scholariq.org/institutions/university-of-yamanashi-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.